Skip to main content

Table 2 Relationships between multiple risk factors and DPN, by univariate and multivariate analysis

From: The relationship between glycemic variability and diabetic peripheral neuropathy in type 2 diabetes with well-controlled HbA1c

Variable

Univariate analysis (OR; 95% CI)

p

Multivariate analysis (OR; 95% CI)

p

Age (year)

1.02 (0.96–1.08)

0.497

–

 

Female, n (%)

1.43 (0.62–3.28)

0.400

–

 

Diabetic duration (year)

1.05 (0.97–1.15)

0.224

–

 

Insulin treatment, n (%)

2.13 (0.84–5.36)

0.111

–

 

Lifestyle intervention, n (%)

0.34 (0.11–1.08)

0.067

–

 

Hypertension, n (%)

0.58 (0.25–1.35)

0.205

–

 

Stain medication, n (%)

1.88 (0.69–5.11)

0.216

–

 

Current drinking, n (%)

1.20 (0.52–2.74)

0.673

–

 

Current smoking, n (%)

1.32 (0.57–3.06)

0.521

–

 

BMI (kg/m2)

0.82 (0.72–0.94)

0.005

0.85(0.73–0.99)

0.033

Height (m)

0.97 (0.92–1.03)

0.356

–

 

TG (mmol/L)

0.80 (0.62–1.04)

0.097

–

 

TC (mmol/L)

0.63 (0.42–0.93)

0.020

–

 

HDLC (mmol/L)

0.26 (0.06–1.16)

0.078

–

 

LDLC (mmol/L)

0.40 (0.20–0.80)

0.009

–

 

eGFR (ml/min/1.73 m2)

1.00 (0.98–1.01)

0.478

–

 

Matsuda ISI

1.04 (0.59–1.85)

0.891

–

 

HbA1c (%)

2.45 (0.79–7.64)

0.122

–

 

Hypoglycemia, n (%)

2.15 (0.50–9.21)

0.301

–

 

SDBG (mmol/L)

2.95 (1.55–5.61)

0.001

–

 

MODD (mmol/L)

4.38 (1.48–12.93)

0.008

–

 

MAGE (mmol/L)

2.18 (1.47–3.24)

<0.001

2.05 (1.36–3.09)

0.001

  1. Results are given as odds ratios and 95% confidence intervals (OR; 95% CI).
  2. Nagelkerke R2 = 0.317 in multivariate analysis.